After linearization all three plasmids were mixed, electroporated, and administered into a single mouse.
Lyophilized particulate human bone, acquired from the Bone Bank of the Hospital das Clínicas de Curitiba (Curitiba, Paraná, Brazil), was mixed with saline and administered into the right maxillary sinus until thoroughly compacted.
For infants, drugs were crushed, mixed with water and administered as slurry.
The participants were blinded to their allocation; L. paracasei F19 was mixed with maltodextrin and administered in sachets and the indistinguishable placebo product was administered in sachets with a corresponding dose of maltodextrin.
Study medications administered to older children (> 5 years of age) and adults were given as tablets or fractions of tablets orally with a glass of water and those given to young children (≤ 5 years of age) were crushed, mixed with water, and administered as a slurry if the children were unable to swallow.
Phase I and II study of DTP-HB-Hib vaccine showed that DTP-HB vaccine was subsequently shown to be immunogenic and well tolerated when mixed with Hib vaccine and administered as a single injection (DTP-HB-Hib) and already routinely used in many countries in the world [ 7– 9].
A TGF-beta type I receptor kinase inhibitor, Ki26894, was mixed with food (0.08%) and administered orally via chow as previously reported.[29] The treatment with Ki26894 was initiated 1 day after the inoculation of INA6 cells.
O-(Benzotriazol-1-yl)- N, N, N′, N′-tetramethyluronium hexafluorophosphate (HBTU, 0.6 M in N, N-dimethylformamide, 210 μL), 4-methylmorpholine (45% in N, N-dimethylformamide, 60 μL), 1-methyl-2-pyrrolidinone (5 μL) and Fmoc-protected amino acid (0.6 M in N, N-dimethylformamide, 220 μL) were mixed (activation time: 2 min) and administered onto the resin.
